Showing results (231-240 of 301) with videos related to

Sort By:
Pageof 31
Case Reports in Gastroenterology|June 14, 2014
Spontaneous massive necrosis of hepatocellular carcinoma with narrowing and occlusion of the arteries and portal veinsTakahiro Tomino, Yo-Ichi Yamashita, Tomohiro Iguchi, et al.
Transplantation Proceedings|November 17, 2022
Autoimmune Hepatitis in an Immunosuppression-Free Patient Who Underwent Living Donor Liver Transplantation From an Identical Twin: A Case ReportKatsuya Toshida, Takeo Toshima, Noboru Harada, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|January 1, 2024
Association of gut microbiota with portal vein pressure in patients with liver cirrhosis undergoing living donor liver transplantationKatsuya Toshida, Shinji Itoh, Yukiko Kosai-Fujimoto, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 31, 2024
Impact of ACSL4 on the prognosis of hepatocellular carcinoma: Association with cancer-associated fibroblasts and the tumour immune microenvironmentKatsuya Toshida, Shinji Itoh, Norifumi Iseda, et al.
Surgical Case Reports|October 6, 2022
Caution for living donor liver transplantation with congenital portosystemic shunt: a case reportYoshihiro Nagao, Katsuya Toshida, Akinari Morinaga, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|July 15, 2021
Impact and risk factors for skeletal muscle mass loss after hepatic resection in patients with hepatocellular carcinomaShinji Itoh, Tomoharu Yoshizumi, Takahiro Tomiyama, et al.
Clinical Calcium|October 1, 2014
[Transdisciplinary Approach for Sarcopenia. Clinical significance of sarcopenia in the patients with chronic liver disease]Ken Shirabe, Norifumi Harimoto, Toru Ikegami, et al.
Journal of Cellular Physiology|October 18, 2016
p62 Promotes Amino Acid Sensitivity of mTOR Pathway and Hepatic Differentiation in Adult Liver Stem/Progenitor CellsMasakazu Sugiyama, Tomoharu Yoshizumi, Yoshihiro Yoshida, et al.
Cancer Medicine|April 18, 2025
Differences in Tumor-Infiltrating Lymphocyte Counts in the Peritumoral Area in Patients Undergoing Hepatic Resection After Lenvatinib and Atezolizumab Plus Bevacizumab Therapy for Hepatocellular CarcinomaKatsuya Toshida, Shinji Itoh, Yasushi Tanaka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 28, 2022
The ratio of serum des-gamma-carboxy prothrombin to tumor volume as a new biomarker for early recurrence of resected hepatocellular carcinomaTomonari Shimagaki, Tomoharu Yoshizumi, Shinji Itoh, et al.
Pageof 31